300 related articles for article (PubMed ID: 27428431)
21. Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota.
Deusch S; Serrano-Villar S; Rojo D; Martínez-Martínez M; Bargiela R; Vázquez-Castellanos JF; Sainz T; Barbas C; Moya A; Moreno S; Gosalbes MJ; Estrada V; Seifert J; Ferrer M
AIDS; 2018 Jun; 32(10):1229-1237. PubMed ID: 29683848
[TBL] [Abstract][Full Text] [Related]
22. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
[TBL] [Abstract][Full Text] [Related]
23. Microbiota and Probiotics in Health and HIV Infection.
D'Angelo C; Reale M; Costantini E
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28621726
[TBL] [Abstract][Full Text] [Related]
24. Poor functional immune recovery in aged HIV-1-infected patients following successfully treatment with antiretroviral therapy.
Kasahara TM; Hygino J; Andrade RM; Monteiro C; Sacramento PM; Andrade AF; Bento CA
Hum Immunol; 2015 Oct; 76(10):701-10. PubMed ID: 26429325
[TBL] [Abstract][Full Text] [Related]
25. The microbiome and HIV persistence: implications for viral remission and cure.
Koay WLA; Siems LV; Persaud D
Curr Opin HIV AIDS; 2018 Jan; 13(1):61-68. PubMed ID: 29135490
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
27. Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).
Piroth L; Moinot L; Yeni P; Avettand-Fénoel V; Reynes J; Girard PM; Marchou B; Georget A; Rouzioux C; Autran B; Duvillard L; Chêne G; Fagard C;
J Antimicrob Chemother; 2016 Feb; 71(2):490-6. PubMed ID: 26568566
[TBL] [Abstract][Full Text] [Related]
28. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
[TBL] [Abstract][Full Text] [Related]
29. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism.
Vujkovic-Cvijin I; Dunham RM; Iwai S; Maher MC; Albright RG; Broadhurst MJ; Hernandez RD; Lederman MM; Huang Y; Somsouk M; Deeks SG; Hunt PW; Lynch SV; McCune JM
Sci Transl Med; 2013 Jul; 5(193):193ra91. PubMed ID: 23843452
[TBL] [Abstract][Full Text] [Related]
30. High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy.
Kaur US; Shet A; Rajnala N; Gopalan BP; Moar P; D H; Singh BP; Chaturvedi R; Tandon R
Sci Rep; 2018 Dec; 8(1):17679. PubMed ID: 30518941
[TBL] [Abstract][Full Text] [Related]
31. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
[TBL] [Abstract][Full Text] [Related]
32. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.
Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT
Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319
[TBL] [Abstract][Full Text] [Related]
33. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
34. Association Between Gut Microbiota and CD4 Recovery in HIV-1 Infected Patients.
Lu W; Feng Y; Jing F; Han Y; Lyu N; Liu F; Li J; Song X; Xie J; Qiu Z; Zhu T; Routy B; Routy JP; Li T; Zhu B
Front Microbiol; 2018; 9():1451. PubMed ID: 30034377
[TBL] [Abstract][Full Text] [Related]
35. Immunosenescence of the CD8(+) T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue, metabolism, and muscle in antiretroviral therapy-treated HIV-infected patients and controls.
Tavenier J; Langkilde A; Haupt TH; Henriksen JH; Jensen FK; Petersen J; Andersen O
BMC Immunol; 2015 Nov; 16():72. PubMed ID: 26611787
[TBL] [Abstract][Full Text] [Related]
36. Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections.
Sagoe KW; Duedu KO; Ziga F; Agyei AA; Adiku TK; Lartey M; Mingle JA; Arens M
Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):38. PubMed ID: 27251610
[TBL] [Abstract][Full Text] [Related]
37. Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy.
Peltenburg NC; Schoeman JC; Hou J; Mora F; Harms AC; Lowe SH; Bierau J; Bakker JA; Verbon A; Hankemeier T; Boonstra A
Sci Rep; 2018 Nov; 8(1):16947. PubMed ID: 30446683
[TBL] [Abstract][Full Text] [Related]
38. Thymic Function during 12 Months of Highly Active Antiretroviral Therapy in Thai HIV-Infected Patients with Normal and Slow Immune Recovery.
Kingkeow D; Srithep S; Praparattanapan J; Supparatpinyo K; Pornprasert S
Jpn J Infect Dis; 2015; 68(5):353-6. PubMed ID: 25720642
[TBL] [Abstract][Full Text] [Related]
39. Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System.
Liu J; Williams B; Frank D; Dillon SM; Wilson CC; Landay AL
J Immunol; 2017 Jan; 198(2):605-614. PubMed ID: 28069756
[TBL] [Abstract][Full Text] [Related]
40. Alterations in children's sub-dominant gut microbiota by HIV infection and anti-retroviral therapy.
Nguyen QT; Ishizaki A; Bi X; Matsuda K; Nguyen LV; Pham HV; Phan CTT; Phung TTB; Ngo TTT; Nguyen AV; Khu DTK; Ichimura H
PLoS One; 2021; 16(10):e0258226. PubMed ID: 34634074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
